Feb 2017 – PathogenDx is pleased to announce that it has submitted an article to the American Oil & Chemical Society on Simplified, highly-multiplex pathogen analysis for agricultural, food, water, environmental sampling. The article will be published in April 2017
Feb 2017 – PathogenDx is pleased to announce that it has signed commercial agreements with three leading testing labs across the United States to supply its PDx-C Ultra-Rapid Microbial Testing technology. Shipment of equipment and kits will begin in March 2017
Jan 2017 – PathogenDx is pleased to announce that it has signed a National Sales and Distribution agreement with Emerald Scientific, the leading national analytical supplies company to the cannabis sector to supply it PDx-C Ultra-Rapid Microbial testing technology to cannabis testing labs
December 2016 – Steep Hill Labs, the worlds largest cannabis testing lab, has decided to adopt PathogenDx’s ultra-rapid microbial testing technology for commercial testing for cannabis testing to the Berkeley, California requirements starting January 2017
December 2016 – Confidence Analytics, one of our validation labs, published the validation report for the state of Washington regulators. PDx-C is going live in Washington in January 2017
November 2016 – Milan Patel, CEO, presents at Arcview and MJIC in Las Vegas detailing the benefits of the PDx Technology and received multiple new investors interested in joining the team.
October 2016 – PDx submits validation for Alaska with Steephill Labs and receives approval to test for E-Coli, Salmonella, and Aspergillus at the below 1 CFU standard.
September 2016 – Dr. Hogan, CSO, presents PDx technology at AOAC National Conference on 19 September 2016 demonstrating our results from our validation test for Alaska.
September 2015 – The company raised initial capital sufficient to complete development of its PDx-C test for the market. It continues to seek growth capital to officially commercialize the technology to labs within the testing sector.
September 2015 – The company officially plans to launch its Early Adopter program date for PDx-C on 1 Oct, 2015
September 2015 – PathogenDx has completed development of an alpha version of its PDx-M testing technology for meat contamination/adulteration for the market. The beta version is expected to be completed by end of Q4 2015, for official roll-out to the market in early 2016
August 2015 – PathogenDx successfully set up its licensed and certified testing collaborators with its PDx-C testing technology to run field samples for rapid microbial testing
June 2015 – PathogenDx was one of twelve selected companies to present at the Arcview Investor conference in Denver, Colorado.
May 2015 – PathogenDx is in final stages of refining its PDx-C test for microbial testing in the cannabis market through beta validation with its collaborating lab partners. The test is expected to be available by late Q3/early Q4 2015 to labs.
March 2015 – PathogenDx has completed preliminary testing of food on its PDx-A testing technology, showing compelling results of technology feasibility within a fraction of the time of conventional testing methods.
November 2014 – PathogenDx is currently in collaboration with testing labs in Arizona, Colorado and State of Washington to bring to market its C-Chip Test for the Cannabis Industry.